Guobang Pharma Ltd.

70
Buy
  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100004NS2
CNY
23.28
0.02 (0.09%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Operating Income
5,844.00
5,313.00
5,687.00
4,480.00
4,181.00
3,802.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
5,844.00
5,313.00
5,687.00
4,480.00
4,181.00
3,802.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
249.00
Operating Expenses
32.00
27.00
20.00
31.00
47.00
33.00
General and Administration Expenses
298.00
316.00
315.00
278.00
224.00
213.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
5,002.00
4,660.00
4,712.00
3,613.00
3,162.00
3,178.00
Operating Profit (PBDIT) excl Other Income
841.00
653.00
975.00
867.00
1,019.00
623.00
Other Income
79.00
88.00
103.00
16.00
-12.00
27.00
Operating Profit (PBDIT)
1,345.00
1,037.00
1,313.00
1,036.00
1,149.00
749.00
Interest
32.00
27.00
20.00
31.00
47.00
33.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
430.00
322.00
261.00
202.00
157.00
139.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
890.00
697.00
1,036.00
808.00
944.00
576.00
Provision for Tax
107.00
87.00
115.00
100.00
133.00
81.00
Profit After Tax
781.00
612.00
920.00
706.00
810.00
314.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
1.40
1.10
1.65
1.26
1.45
0.56
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 9.99% vs -6.59% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 28.88% vs -33.06% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 18.29% vs 37.20% in Dec 2023

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2024 is 27.61% vs -33.49% in Dec 2023

Compare Profit and Loss Results of Guobang Pharma Ltd.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
No of Months
12
12
Operating Income
5,844.00
0
5,844.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
5,844.00
0
5,844.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0
0.00
0%
Raw Materials Consumed
0.00
0
0.00
0%
Power & Fuel Cost
0.00
0
0.00
0%
Employee Cost
0.00
0
0.00
0%
Operating Expenses
32.00
0
32.00
0%
General and Administration Expenses
298.00
0
298.00
0%
Selling and Distribution Expenses
0.00
0
0.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
0.00
0
0.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
5,002.00
0
5,002.00
0%
Operating Profit (PBDIT) excl Other Income
841.00
0.00
841.00
0%
Other Income
79.00
0
79.00
0%
Operating Profit (PBDIT)
1,345.00
0
1,345.00
0%
Interest
32.00
0
32.00
0%
Profit before Depriciation and Tax
0.00
0
0.00
0%
Depreciation
430.00
0
430.00
0%
Profit Before Taxation & Exceptional Items
0.00
0
0.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
890.00
0
890.00
0%
Provision for Tax
107.00
0
107.00
0%
Profit After Tax
781.00
0
781.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
0.00
0
0.00
0%
Profit Available for appropriations
0.00
0
0.00
0%
Appropriations
0.00
0
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
1.3989
0
1.40
0%
Profit And Loss - Net Sales
Net Sales 5,844.20 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 9.99% vs -6.59% in Dec 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 841.65 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 28.88% vs -33.06% in Dec 2023

Profit And Loss - Interest
Interest 32.58 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 18.29% vs 37.20% in Dec 2023

Profit And Loss - Profit After Tax
Profit After Tax 781.60 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 27.61% vs -33.49% in Dec 2023